increas
incid
fatal
microbi
infect
due
develop
resist
licens
antimicrobi
drug
rais
strong
demand
new
antimicrobi
treatment
strategi
filament
ascomycet
rich
sourc
antimicrobi
biomolecul
potenti
wide
applic
medicin
agricultur
prevent
treat
microbi
industri
relev
fungu
penicillium
chrysogenum
wellknown
produc
antibiot
penicillin
also
secret
small
cysteinerich
cation
protein
antimicrobi
activ
p
chrysogenum
ideal
produc
bioproduct
benefici
potenti
mankind
ferment
bulk
product
easi
importantli
recogn
safe
organ
us
food
drug
administr
p
chrysogenum
strain
ancestor
industri
strain
use
penicillin
product
strain
wisconsin
whose
genom
sequenc
publicli
avail
p
chrysogenum
secret
antifung
protein
paf
whose
structur
function
properti
extens
paf
repres
promis
biomolecul
novel
antifung
drug
develop
stabl
proteolyt
degrad
thermoresist
activ
within
broad
ph
show
cytotox
effect
furthermor
paf
could
serv
potenti
biopesticid
agricultur
imped
infect
plantpathogen
genom
mine
strain
wisconsin
nucleotid
nt
sequenc
code
small
cysteinerich
cation
protein
reveal
p
chrysogenum
strain
harbour
apart
paf
gene
ncbi
access
two
gene
code
protein
potenti
antimicrobi
activ
product
first
gene
ncbi
access
ident
pcarctin
isol
arctic
p
chrysogenum
strain
repres
orthologu
bubbl
protein
isol
exud
penicillium
product
second
gene
genebank
access
ortholog
pgafp
identifi
supernat
p
chrysogenum
strain
origin
isol
drycur
ham
et
thu
genom
p
chrysogenum
wisconsin
progenitor
strain
contain
least
three
gene
code
protein
report
antifung
activ
repres
uniqu
chanc
investig
function
within
one
organ
paf
pgafp
pcarctin
common
encod
preproprotein
contain
signal
peptid
follow
prosequ
remov
protein
matur
process
secret
cultur
matur
protein
cation
due
high
content
amino
acid
aa
posit
charg
sidechain
phylogenet
analys
suggest
classif
three
protein
differ
group
wherebi
pcarctin
group
distantli
paf
predict
pgafportholog
protein
p
chrysogenum
isol
character
date
high
thermo
ph
proteas
stabil
report
matur
pgafp
strain
potent
growth
inhibitori
activ
toxigen
mould
dryripen
sausag
render
protein
interest
control
unwant
food
present
studi
isol
studi
pgafp
ortholog
protein
p
chrysogenum
address
unansw
question
concern
solut
structur
antimicrobi
specif
mode
action
distinguish
two
protein
origin
two
differ
p
chrysogenum
strain
name
protein
strain
p
chrysogenum
antifung
protein
b
pafb
analog
nomenclatur
alreadi
extens
studi
homolog
protein
paf
p
chrysogenum
adapt
recent
describ
p
chrysogenumbas
express
gener
suffici
amount
pafb
function
structur
character
use
pafdefici
p
chrysogenum
strain
recipi
ensur
optim
high
yield
pafb
product
avoid
coexpress
relat
antifung
protein
paf
identifi
disulphidebond
stabil
compact
structur
pafb
found
apart
growth
inhibitori
activ
mould
yeast
antivir
activ
never
report
member
small
cation
cysteinerich
protein
group
ascomycet
effort
fail
far
identifi
pafb
supernat
cell
extract
p
chrysogenum
grown
standard
condit
shake
cultur
minim
medium
mm
day
fig
true
p
chrysogenum
strain
lack
pafencod
examin
mutant
increas
chanc
identifi
pafb
absenc
paf
data
shown
therefor
perform
northern
blot
analys
determin
abund
time
pafb
transcript
surprisingli
found
pafb
mrna
detect
p
chrysogenum
shake
cultur
express
maximum
h
inocul
subsequ
decreas
transcript
amount
upon
incub
time
fig
contrast
gene
transcript
paf
could
detect
h
inocul
onward
transcript
reach
maximum
h
fig
express
pattern
correl
secret
paf
protein
cultur
broth
p
chrysogenum
stationari
growth
phase
result
confirm
western
blot
use
specif
antipaf
fig
supplementari
method
incorrect
mrna
process
could
result
defect
protein
translat
product
nonsens
protein
product
readili
therefor
next
investig
pafb
mrna
correctli
splice
verif
pafb
mrna
sequenc
done
cdna
synthesi
pcr
amplif
pafb
specif
transcript
subsequ
sanger
sequenc
obtain
sequenc
match
exon
pafb
fragment
p
chrysogenum
wisconsin
yield
intact
pafb
open
read
frame
indic
correct
splice
supplementari
fig
similar
paf
two
short
intron
nt
nt
length
respect
present
pafb
contain
consensu
donor
site
gt
consensu
acceptor
site
ag
consensu
sequenc
intern
put
lariat
format
element
rctrac
found
first
intron
second
noncod
sequenc
supplementari
fig
nt
sequenc
pafb
cdna
deposit
european
nucleotid
archiv
ena
access
code
aa
protein
supplementari
tabl
comparison
pafb
primari
sequenc
ortholog
pgafp
reveal
pafb
differ
three
aa
result
ident
protein
fig
histidin
glutamin
substitut
posit
resid
presequ
serin
asparagin
threonin
arginin
substitut
posit
respect
occur
prosequ
fig
predict
matur
pafb
protein
exhibit
ident
matur
pgafp
fig
similar
pafb
paf
preproprotein
matur
protein
fig
could
detect
isol
pafb
p
chrysogenum
cultur
supernat
employ
p
chrysogenumbas
express
produc
recombin
pafb
structur
analysi
function
test
end
p
chrysogenum
strain
transform
pstilinear
plasmid
carri
pafb
gene
control
strong
paf
posit
transform
ptraresist
p
chrysogenum
clone
test
highest
protein
secret
time
cours
h
use
smallscal
ferment
data
shown
southern
blot
experi
best
pafb
produc
clone
p
chrysogenum
pafb
reveal
multipl
random
integr
event
transform
dna
fungal
genom
supplementari
fig
clone
select
cultiv
larg
scale
cultur
condit
pafb
purifi
cellfre
cultur
broth
singlestep
chromatographi
protein
yield
mgl
supernat
reach
puriti
ident
pafb
verifi
sodiumdodecylsulph
polyacrylamid
gel
electrophoresi
sdspage
electrospray
ioniz
mass
spectrometri
esim
respect
fig
sdspa
gel
one
singl
band
pafb
visibl
elut
fraction
fig
esim
detect
one
main
peak
correspond
averag
mass
kda
repres
fulllength
pafb
fig
two
smaller
peak
correspond
kda
kda
correl
two
ntermin
truncat
pafb
form
kda
peak
correspond
variant
without
ntermin
leucin
kda
peak
form
lack
ntermin
residu
leucin
serin
fig
supplementari
tabl
averag
molecular
mass
three
peak
match
calcul
theoret
molecular
mass
protparam
tool
expasi
oxid
protein
form
indic
presenc
three
intramolecular
disulphid
bond
three
pafb
protein
variant
lack
posttransl
modif
except
cleavag
preprosequ
report
wildtyp
use
purifi
recombin
pafb
gener
polyclon
antipafb
antibodi
aim
identifi
pafb
higher
specif
sensit
supernat
cell
extract
p
chrysogenum
shake
cultur
western
blot
techniqu
supplementari
method
polyclon
antipafb
antibodi
specif
recogn
recombin
pafb
paf
western
blot
supplementari
fig
howev
pafbspecif
signal
could
identifi
p
chrysogenum
supernat
cell
extract
growth
condit
appli
support
observ
pafb
present
concentr
suffici
detect
although
encod
gene
transcrib
supplementari
fig
obtain
structur
inform
pafb
atom
resolut
solut
nuclear
magnet
reson
nmr
spectroscopi
experi
perform
accord
esim
data
three
isoform
unlabel
pafb
present
solut
ms
peak
intens
fig
nmr
pafb
suggest
fulllength
pafb
sequenc
residu
domin
form
mixtur
nmr
spectra
ms
analysi
pafb
howev
identifi
shortest
sequenc
aa
supplementari
fig
name
short
pafb
variant
shortform
pafb
sfpafb
aa
sequenc
number
refer
variant
base
tripl
reson
nmr
spectra
amid
hn
nh
atom
could
found
assign
heteronuclear
singl
quantum
correl
hsqc
spectrum
sfpafb
supplementari
fig
except
first
ntermin
residu
protein
detect
spectrum
resid
middl
big
flexibl
loop
adjac
fig
show
visibl
amid
nh
signal
howev
signal
belong
unambigu
assign
ca
note
sampl
miss
nh
signal
could
found
two
overlaid
spectra
short
fulllength
form
pafb
exhibit
good
agreement
peak
supplementari
fig
structur
calcul
base
measur
form
decid
solv
structur
sfpafb
discuss
detail
indic
structur
pafb
sfpafb
would
exhibit
differ
except
nterminu
extent
backbon
assign
consid
hn
hn
c
atom
sfpafb
reach
extent
assign
proton
includ
side
chain
hydrogen
atnoscandidcyana
run
nuclear
overhaus
effect
noe
consid
seventh
cycl
result
averag
noesresidu
abund
distanc
inform
compar
size
protein
result
welldefin
structur
low
backbon
rmsd
valu
final
model
chemic
shift
data
nmr
experiment
paramet
submit
bmrb
entri
structur
model
sfpafb
deposit
protein
data
bank
id
structur
sfpafb
contain
two
orthogon
pack
triplestrand
sheet
fig
note
five
strand
present
protein
first
share
sheet
locat
residu
well
respect
strand
connect
three
small
loop
one
larg
loop
compris
motiv
fig
final
two
sheet
follow
pattern
respect
six
highli
conserv
cystein
amino
acid
sequenc
sfpafb
form
three
disulphid
bond
cystein
well
note
pattern
abcabc
creat
hidden
central
core
region
loop
form
turn
conform
secondari
structur
analysi
show
presenc
bend
flexibl
glycineglycin
motiv
contain
loop
second
third
rel
hydrophob
compar
part
protein
charg
residu
contrast
central
part
loop
socal
larg
loop
contain
three
conserv
lysin
residu
togeth
form
posit
charg
surfac
region
gener
larg
loop
adopt
bent
conform
ctermin
end
structur
form
sidechain
close
respect
interestingli
strand
middl
second
exhibit
high
neg
charg
densiti
nevertheless
sever
basic
amino
acid
vicin
potenti
also
form
saltbridg
although
strand
rel
short
sever
hbond
found
strand
stabil
second
sidechain
interact
togeth
apolar
amino
acid
form
hydrophob
core
sfpafb
final
fifth
amphipath
ctermin
region
sfpafb
adopt
particular
regular
secondari
structur
despit
rel
low
sequenc
similar
structur
sfpafb
highli
similar
paf
determin
previous
protein
data
bank
id
protein
adopt
greek
key
supersecondari
structur
global
fold
ident
disulphid
bond
pattern
abcabc
order
compar
local
conform
structur
two
protein
superimpos
rmsd
valu
overal
fig
except
nterminu
howev
turn
conform
loop
also
show
substanti
differ
paf
sfpafb
unexpect
second
half
loop
one
highli
conserv
region
protein
longest
patch
conserv
residu
asparaginelysinelysinecystein
locat
fig
wherea
gener
show
lower
level
sequenc
conserv
protein
adopt
bent
structur
region
paf
result
turnlik
conform
residu
amino
acid
respect
contrast
latter
turn
present
sfpafb
posit
also
note
although
high
densiti
posit
surfac
charg
believ
major
contributor
activ
four
lysin
residu
conserv
paf
pafb
furthermor
pafb
lack
belt
structur
align
lysin
residu
ly
paf
gener
lower
overal
posit
surfac
charg
differ
surfac
electrostat
potenti
fig
assess
possibl
differ
sfpafb
fulllength
protein
built
firstapproxim
structur
model
fulllength
pafb
ad
leucineserin
segment
nterminu
experiment
sfpafb
structur
short
molecular
dynam
md
run
suggest
fulllength
nterminu
might
align
strand
residu
form
ntermin
longer
sfpafb
form
similar
case
paf
supplementari
fig
also
plausibl
base
favour
interact
sfpafb
number
form
md
calcul
nevertheless
expect
structur
sfpafb
fulllength
pafb
exhibit
substanti
differ
final
variat
nterminu
dramat
chang
biophys
featur
pafb
form
isoelectr
point
pi
net
charg
grand
averag
hydropathi
gravi
supplementari
tabl
growth
inhibitori
activ
pafb
test
filament
fungi
yeast
bacteria
microtit
plate
assay
determin
minim
inhibitori
concentr
mic
tabl
paf
use
control
comparison
among
filament
fungi
test
model
organ
neurospora
crassa
show
highest
pafbsensit
mic
pdb
follow
opportunist
human
pathogen
aspergillu
fumigatu
mic
trichophyton
rubrum
mic
aspergillu
terreu
interestingli
low
dose
pafb
selfinhibit
activ
produc
strain
p
chrysogenum
pdb
stand
contrast
paf
affect
germin
p
chrysogenum
concentr
test
far
antiyeast
activ
report
pgafp
malt
extract
paf
ypd
found
howev
clear
inhibitori
activ
pafb
paf
mic
model
yeast
saccaromyc
cerevisia
opportunist
human
pathogen
candida
albican
respect
cultiv
pdb
contrast
antibacteri
activ
pafb
could
observ
administ
concentr
rang
gramneg
escherichia
coli
gramposit
bacillu
subtili
similar
found
paf
pafb
effici
prevent
conidi
germin
test
filament
fungi
respect
mic
except
n
crassa
similar
previou
observ
n
crassa
conidia
still
germin
presenc
pafb
elong
germ
tube
inhibit
irrespect
cultur
medium
appli
pdb
vogel
growth
inhibitori
activ
pafb
character
n
crassa
vogel
medium
pafb
exhibit
compar
mic
pdb
tabl
n
crassa
conidia
expos
pafb
h
vogel
medium
germin
significantli
lower
rate
p
untreat
control
tabl
pafexposur
contrast
influenc
germin
effici
conidia
germin
presenc
paf
compar
untreat
control
tabl
furthermor
pafb
significantli
reduc
germ
tube
length
h
old
germl
mic
correspond
reduct
compar
untreat
control
p
contrast
paf
reduc
germ
tube
length
less
sever
mic
p
compar
control
tabl
increas
pafb
paf
concentr
mic
respect
aggrav
effect
n
crassa
data
shown
thu
find
indic
pafb
affect
coloni
establish
n
crassa
effect
paf
great
relev
antifung
drug
act
fungicid
rather
fungistat
reduc
risk
resist
develop
occur
readili
drug
show
fungistat
activ
therefor
test
fungicid
potenti
pafb
paf
widespread
human
opportunist
pathogen
c
albican
caus
candidiasi
end
c
albican
cell
incub
antifung
protein
concentr
correspond
mic
h
control
h
h
pdb
plate
appropri
dilut
onto
pda
plate
allow
surviv
cell
establish
coloni
shown
fig
viabil
significantli
reduc
h
incub
presenc
pafb
dosedepend
manner
surviv
rate
p
p
p
compar
viabil
respect
control
h
incub
set
respect
fungicid
potenti
increas
c
albican
cell
expos
pafb
h
compar
surviv
rate
control
p
p
p
cell
surviv
expos
respect
fig
similarli
c
albican
cell
expos
paf
show
reduc
viabil
h
incub
fig
fungicid
effect
paf
howev
less
pronounc
pafb
surviv
rate
p
paf
p
paf
p
paf
correspond
mic
mic
mic
respect
compar
control
cell
surviv
h
incub
fig
fungicid
effect
detect
paf
longer
incub
time
surviv
rate
h
p
p
respect
fig
wherea
paf
less
effect
low
concentr
mic
shorter
incub
time
h
candida
cell
expos
paf
prolifer
cultiv
h
liquid
pdb
becam
evid
increas
number
coloni
form
unit
plate
pda
plate
result
indic
pafb
act
fast
effici
fungicid
way
c
albican
submic
concentr
previou
studi
report
paf
toxic
sensit
fungi
close
link
activ
intern
therefor
examin
uptak
local
pafb
comparison
paf
n
crassa
p
chrysogenum
c
albican
purpos
pafb
paf
label
green
fluoresc
dye
bodipi
protein
compar
label
effici
antifung
activ
similar
unlabel
protein
data
shown
visual
fluoresc
signal
protein
conjug
appli
conidia
n
crassa
p
chrysogenum
allow
germin
h
cell
c
albican
grow
h
presenc
bodipypafb
bodipypaf
respect
fungal
cell
costain
propidiumiodid
pi
test
cell
viabil
shown
fig
b
c
bodipylabel
protein
local
germl
n
crassa
c
albican
cell
undoubtedli
show
sign
cell
death
posit
pi
stain
observ
p
chrysogenum
germl
bodipypafb
uptak
correl
pi
stain
contrast
neither
detect
bodipypaf
uptak
pi
stain
p
chrysogenum
fig
observ
match
differ
suscept
p
chrysogenum
pafb
paf
describ
tabl
provid
evid
antifung
toxic
pafb
paf
close
link
uptak
fungal
cell
analys
uptak
mechan
bodipypafb
n
crassa
time
cours
experi
min
incub
bodipypafb
alreadi
attach
envelop
n
crassa
conidia
intracellular
signal
visibl
fig
prolong
incub
time
h
pafb
signal
cytoplasm
steadili
increas
coincid
posit
pi
stain
fig
interestingli
fungal
cell
show
sign
cell
death
long
bodipypafb
resid
vacuol
fig
investig
next
step
whether
pafb
enter
cell
activ
passiv
eg
diffus
end
expos
hold
germin
conidia
carbonyl
cyanid
mchloropheylhydrazon
cccp
inhibitor
oxid
phosphoryl
atp
product
respect
min
bodipypafb
ad
h
incub
shown
fig
bodipypafb
remain
attach
outer
layer
taken
n
crassa
cell
presenc
inhibitor
fig
contrast
bodipypafb
local
vacuol
germl
expos
inhibitor
fig
pafb
uptak
also
inhibit
reduc
cell
metabol
data
shown
observ
prove
stain
specif
bodipypafb
indic
intern
bodipypafb
depend
activ
cellular
metabol
neg
pi
stain
confirm
viabil
cell
appli
test
condit
recent
holthausen
et
al
report
efficaci
host
defens
peptid
skin
south
indian
frog
treat
respiratori
viral
infect
case
human
influenza
studi
examin
select
antivir
potenti
pafb
paf
reduc
infect
human
epitheli
cell
line
human
coronaviru
strain
hcov
vitro
first
confirm
pafb
similarli
paf
show
cytotox
effect
host
cell
appli
concentr
rang
supplementari
fig
antivir
activ
protein
express
term
protein
concentr
protect
virusinduc
cytopathogen
effect
cpe
cell
syncytia
format
vacuol
cell
round
detach
cell
death
fig
determin
minimum
effect
protein
concentr
reduc
virusinduc
cpe
preserv
cell
monolay
integr
fig
b
antivir
effici
could
observ
viru
infect
cell
differ
viral
titr
multipl
infect
moi
supplementari
fig
reach
maximum
inhibit
valu
pafb
hcov
moi
fig
paf
contrast
inhibit
hcov
cpe
less
effect
pafb
still
exhibit
antivir
activ
especi
lower
viral
titer
paf
reduc
viral
cpe
moi
fig
b
applic
higher
protein
concentr
howev
increas
antivir
effect
pafb
paf
supplementari
fig
antivir
efficaci
protein
also
confirm
immunofluoresc
experi
pafb
paf
success
reduc
number
hcov
infect
cell
fig
hcov
local
examin
virusspecif
antibodi
h
post
infect
viral
replic
transcript
underway
shown
fig
strong
virusspecif
green
fluoresc
signal
observ
major
hcov
infect
cell
moi
without
pafb
paf
treatment
signal
intens
number
viru
infect
cell
significantli
decreas
presenc
pafb
paf
fig
observ
suggest
antivir
effect
protein
may
reduc
final
stage
viral
replic
cycl
cpe
also
earlier
step
infect
andor
spread
viral
particl
studi
provid
detail
insight
antimicrobi
activ
structur
secret
pafb
protein
penicillinproduc
mould
p
chrysogenum
protein
belong
group
small
cysteinerich
cation
protein
ascomycet
although
pafb
encod
gene
abundantli
transcrib
could
detect
translat
gene
product
cultiv
condit
appli
phenomenon
uniqu
recent
garrigu
et
al
report
identif
genom
encod
antifung
protein
afpb
penicillium
digitatum
fail
although
gene
transcrib
high
instead
antifung
activ
cryptic
protein
success
analys
map
antifung
motif
afpb
synthet
cysteinecontain
recombin
fulllength
afpb
gener
recent
function
analysi
appli
p
chrysogenumbas
express
reason
remain
obscur
time
express
correctli
process
pafb
mrna
translat
detect
protein
amount
p
chrysogenum
conidia
p
chrysogenum
pafb
suscept
seem
product
pafb
need
strict
regul
avoid
selflimit
hand
preexist
pool
mrna
may
serv
reservoir
allow
fast
avail
case
urgent
need
eg
fast
respons
chang
environment
development
stimuli
inde
function
cysteinerich
cation
protein
beyond
fungal
growth
inhibit
stress
respons
asexu
develop
support
fit
produc
mould
report
recent
publish
transcriptom
metaanalysi
express
regul
aspergillu
niger
antifung
protein
anafp
underlin
role
protein
stress
respons
growth
develop
nutrient
recycl
thu
pafb
mrna
may
store
exampl
process
bodi
stress
granul
describ
cerevisia
mammalian
cell
pafb
protein
current
investig
assumpt
appli
p
chrysogenumbas
express
system
gener
pafb
suffici
quantiti
high
qualiti
function
structur
analys
strong
paf
promot
presenc
multipl
gene
copi
andor
possibl
genom
integr
site
respons
bulk
product
recombin
fact
recombin
pafb
produc
p
chrysogenum
without
problem
indic
regulatori
element
like
present
andor
region
pafb
mrna
respons
control
mrna
translat
andor
storag
wildtyp
replac
pafb
express
cassett
matur
pafb
purifi
major
fulllength
form
aa
two
less
abund
short
variant
aa
aa
respect
anoth
member
protein
group
aspergillu
giganteu
afp
secret
two
natur
occur
ntermin
variant
major
short
form
aa
lower
amount
larger
form
lfafp
contain
six
addit
ntermin
amino
lfafp
remark
differ
afp
pi
gravi
net
charg
show
lower
antifung
date
tell
whether
ntermin
pafb
variant
occur
natur
eg
autocatalyt
activ
whether
consequ
overexpress
condit
latter
observ
exampl
express
recombin
bovin
chymosin
aspergillu
awamori
result
product
variabl
ntermini
like
due
proteolysi
cultur
recombin
paf
produc
high
yield
p
chrysogenum
show
ntermin
variat
wherea
subtl
ntermin
differ
detect
express
p
similarli
afpb
express
p
digitatum
use
pafderiv
express
cassett
result
gene
product
ntermin
none
case
howev
antifung
activ
ntermin
variant
proteolysi
pafb
nterminu
might
influenc
nutrient
composit
ferment
broth
doubl
isotop
label
pafb
sucros
replac
carbon
sourc
growth
medium
might
respons
gener
sfpafb
aa
assumpt
requir
analysi
futur
one
recent
studi
demonstr
ntermin
aa
regul
stabil
fold
antifung
function
recombin
nfap
protein
neosartorya
contrast
found
ntermin
pafb
variant
differ
significantli
overal
solut
structur
physicochem
featur
therefor
assum
antifung
activ
affect
importantli
matur
fulllength
pafb
ident
matur
pgafp
describ
p
chrysogenum
origin
isol
cure
pgafp
shown
sensit
ionic
strength
fungal
cultur
highli
stabl
extrem
ph
high
temperatur
also
true
member
antifung
protein
group
paf
afp
nfap
possess
highli
stabl
disulphidebond
mediat
compact
pafb
show
potent
antifung
activ
model
fungi
human
fungal
pathogen
low
concentr
rang
pafb
prevent
effect
paf
germin
coloni
establish
n
crassa
signific
differ
suscept
test
fungi
eg
terreu
p
chrysogenum
point
toward
differ
mode
action
two
protein
variat
antifung
spectrum
mode
action
report
structur
similar
relat
antifung
protein
paf
afpb
nfap
propos
presenc
activ
host
interact
molecul
regul
uptak
mechan
process
signal
abil
cope
detriment
effect
trigger
antifung
protein
determin
suscept
fungal
speci
furthermor
import
protein
surfac
charg
distribut
describ
paf
function
need
consid
explain
differ
antifung
recombin
pafb
identifi
h
cultiv
reach
maximum
amount
h
standard
medium
mm
perfectli
coincid
onset
product
paf
recombin
paf
variant
gener
express
system
control
paf
interestingli
overproduct
recombin
pafb
affect
prolifer
produc
strain
p
chrysogenum
pafb
although
inhibitori
activ
observ
conidia
microdilut
assay
tabl
one
possibl
explan
phenomenon
could
pafb
express
condit
establish
hyphal
growth
mm
p
chrysogenum
hypha
lack
pafb
suscept
determin
contrast
must
present
pdb
inde
prove
pafb
similarli
paf
interact
p
chrysogenum
hypha
cultiv
mm
supplementari
fig
grown
pdb
hyphal
prolifer
inhibit
pafb
taken
cell
supplementari
fig
paf
hand
neither
interact
p
chrysogenum
conidia
hypha
irrespect
cultur
medium
appli
tabl
supplementari
fig
similar
nutrient
depend
suscept
pafb
paf
observ
yeast
date
potent
antiyeast
activ
report
n
fischeri
protein
kill
yeast
cell
within
minut
plasma
membran
neither
relat
protein
afp
nfap
paf
yeast
inhibitori
activ
ever
interestingli
studi
show
first
time
antiyeast
activ
pafb
paf
dilut
pdb
appar
yeast
cell
exhibit
suscept
determin
protein
cultiv
starvat
medium
time
cours
experi
indic
c
albican
cell
kill
immedi
administr
pafb
paf
cell
death
occur
time
concentr
depend
manner
support
observ
made
far
exclud
fast
kill
mechan
eg
pore
format
point
toward
complex
interact
mechan
target
inde
cell
toxic
pafb
suscept
fungi
studi
correl
activ
protein
intern
subsequ
distribut
cytoplasm
coincid
pi
posit
stain
observ
paf
antifung
peptid
protein
previou
higher
fungicid
activ
pafb
paf
might
result
differ
effici
uptak
andor
reach
effect
kill
concentr
within
cell
investig
need
elucid
mechan
regul
fungal
suscept
kill
kinet
member
protein
group
studi
publish
antivir
activ
antimicrobi
peptid
protein
express
anim
plant
eg
surpris
novel
observ
small
cysteinerich
cation
antimicrobi
protein
fungal
origin
efficaci
pafb
paf
hcov
viru
viru
highli
contagi
caus
mild
coldlik
respiratori
ill
howev
highli
pathogen
hcov
sever
acut
respiratori
syndrom
cov
sarscov
middl
east
respiratori
syndrom
cov
merscov
predominantli
infect
lower
airway
caus
fatal
pneumonia
high
morbid
mortal
antihcov
drug
vaccin
differ
stage
develop
still
lack
pafb
paf
preferenti
low
moi
reduc
virusinduc
cpe
infect
human
cell
thu
promis
potenti
altern
therapeut
approach
human
coronavirus
base
data
collect
studi
suggest
pafb
paf
directli
indirectli
influenc
host
cell
metabol
inhibit
releas
spread
progeni
viru
particl
destroy
hcov
virion
observ
slight
differ
antivir
activ
pafb
paf
may
result
differ
viru
host
cell
suscept
toward
protein
differ
protein
surfac
charg
distribut
outlin
observ
antivir
efficaci
could
increas
higher
protein
concentr
could
attribut
low
bioavail
protein
higher
concentr
partial
cluster
hamper
cross
biomembran
shown
antimicrobi
protein
previou
work
current
progress
get
detail
insight
mode
antivir
action
pafb
paf
importantli
lethal
activ
potenti
drug
toward
human
cell
exclud
harm
side
effect
need
kept
minimum
futur
antimicrobi
drug
develop
similar
afp
toxic
activ
mammalian
cell
detect
pafb
vitro
supplementari
fig
featur
antifungalantivir
potenti
render
pafb
promis
candid
develop
novel
antimicrobi
treatment
strategi
microbi
strain
use
studi
growth
media
list
supplementari
tabl
tabl
respect
propag
vector
plasmid
carri
e
coli
grown
lysogeni
broth
medium
lb
supplement
ampicillin
yeast
grown
potato
dextros
agar
pda
becton
dickinson
solid
yeast
extract
pepton
dextros
medium
ypd
gener
conidia
p
chrysogenum
cultiv
solid
defin
minim
medium
mm
n
crassa
vogel
agar
plate
continu
light
fumigatu
niger
terreu
grown
pda
becton
dickinson
rubrum
grown
oatmeal
agar
conidia
harvest
spore
buffer
nacl
wv
tween
vv
transform
conidia
p
chrysogenum
grown
ml
cm
h
continu
shake
rpm
conidia
p
chrysogenum
p
chrysogenum
pafb
cultiv
ml
mm
h
continu
shake
northern
southern
western
blot
analys
pafb
product
respect
pafb
singl
doubl
isotopelabel
nmr
analysi
carri
replac
nitrogen
andor
carbon
sourc
mm
andor
wv
eurisotop
respect
total
rna
isol
p
chrysogenum
liquid
cultur
use
tri
reagent
sigmaaldrich
ten
rna
per
lane
load
formaldehydeagaros
gel
blot
onto
hybondn
membran
amersham
biosienc
hybrid
digoxigenin
dig
label
probe
roch
primer
pair
opafbfwopafbrev
use
pcrbase
amplif
pafb
paf
specif
hybrid
probe
respect
supplementari
tabl
gener
pafboverproduc
p
chrysogenum
strain
paf
delet
mutant
p
chrysogenum
transform
protoplast
format
transform
psti
linear
carri
accord
cantor
et
transform
singl
spore
three
time
mm
agar
supplement
pyrithiamin
hydrobromid
sigmaaldrich
posit
transform
analys
southern
blot
genom
integr
detail
descript
given
supplementari
method
pafb
paf
produc
purifi
cellfre
supernat
recent
verifi
ident
purifi
pafb
protein
mass
determin
esim
protein
microanalysi
facil
medic
univers
innsbruck
addit
protein
solut
sizefraction
wv
sdspage
three
pafb
sampl
prepar
nmr
studi
unlabel
describ
lyophil
protein
dissolv
mm
acet
buffer
prepar
deuter
acet
acid
ph
fill
shigemi
nmr
sampl
tube
protein
concentr
set
mm
protein
reson
assign
accomplish
strategi
appli
previous
doublelabel
briefli
serv
root
follow
tripl
reson
experi
hnco
hn
ca
co
hnca
hn
co
ca
hncacb
hnha
hbha
co
nh
hn
co
cacb
use
obtain
backbon
signal
reson
assign
side
chain
combin
hc
c
h
cosi
hc
c
h
tocsi
hcc
co
nh
h
cchtocsi
experi
use
aromat
proton
identifi
aid
cb
cgcd
hd
cb
cgcdce
spectra
appli
experi
version
ident
describ
previou
collect
noe
distanc
restraint
noesi
spectra
record
well
noesi
latter
experi
perform
unlabel
pafb
sampl
list
measur
record
bruker
avanc
ii
spectromet
equip
txi
zgradient
probehead
noesytyp
experi
repeat
mhz
spectromet
similar
configur
higher
spectral
resolut
noesi
spectra
less
overlap
crosspeak
help
obtain
distant
restraint
structur
calcul
spectra
acquir
k
data
process
topspin
softwar
sequenti
reson
assign
perform
aid
cara
softwar
chemic
shift
data
export
softwar
cyana
torsion
angl
dynam
use
de
novo
structur
determin
combin
atnoscandid
algorithm
latter
use
peak
pick
noe
assign
setup
file
cyana
prepar
manual
disulphid
connect
defin
cyana
input
assum
abcabc
disulphid
pattern
paf
link
cystein
diastereotop
proton
nonequival
group
consid
stereochem
ambigu
assign
backbon
torsion
angl
constraint
predict
accord
use
refin
structur
model
seven
cycl
cyana
iter
perform
lowest
energi
conform
consid
final
structur
model
chemic
shift
data
nmr
experiment
paramet
submit
bmrb
databank
structur
ensembl
upload
protein
data
bank
id
growth
inhibit
assay
perform
microtit
plate
nunclon
delta
thermo
scientif
conidia
yeast
cell
incub
pdb
becton
dickinson
increas
concentr
pafb
total
volum
bacteria
precultiv
lb
pdb
reach
expos
antimicrobi
treatment
pafb
microbi
growth
monitor
h
measur
fluostar
omega
micropl
reader
bmg
labtech
microscop
use
invert
microscop
leica
dm
il
led
leica
microsystem
imag
taken
axiocam
mr
digit
camera
carl
zeiss
gmbh
process
axiovis
softwar
carl
zeiss
gmbh
mic
defin
minim
protein
concentr
inhibit
growth
compar
untreat
control
refer
growth
germin
effici
germ
tube
length
n
crassa
presenc
pafb
mic
determin
fungistat
fungicid
effect
c
albican
determin
incub
cell
per
ml
pdb
pafb
shake
h
sampl
taken
h
h
h
dilut
pdb
plate
pda
plate
duplic
number
coloni
form
unit
determin
incub
plate
h
surviv
rate
calcul
set
coloni
form
unit
time
point
h
experi
paf
appli
comparison
experi
prepar
technic
triplic
perform
least
twice
green
fluorophor
bodipi
fl
eda
life
technolog
use
protein
label
describ
sonderegg
et
studi
protein
uptak
c
albican
p
chrysogenum
n
crassa
yeast
cellsml
conidiaml
incub
bodipylabel
protein
respect
media
pdb
vogel
analys
within
incub
time
min
h
investig
pafb
uptak
p
chrysogenum
hypha
grown
mm
h
old
mycelia
stain
bodipylabel
pafb
h
costain
pi
min
room
temperatur
carri
monitor
viabil
fungal
cell
posit
stain
control
sampl
treat
vv
ethanol
min
pafbtransport
hypha
investig
n
crassa
conidia
grown
medium
h
incub
mm
sigmaaldrich
cccp
sigmaaldrich
min
respect
bodipylabel
pafb
ad
sampl
microscop
analys
h
incub
microscop
imag
perform
fluoresc
microscop
axioplan
carl
zeiss
gmbh
equip
axiocam
camera
excitationemiss
filter
nm
green
fluoresc
nm
red
fluoresc
carl
zeiss
gmbh
imag
process
edit
done
axiovis
carl
zeiss
gmbh
gimp
gnu
imag
manipul
program
version
wwwgimporg
microsoft
power
point
microsoft
corp
viru
propag
cell
grown
antibioticfre
dulbecco
modifi
eagl
medium
nonessenti
amino
acid
thermo
fisher
scientif
complement
fetal
bovin
serum
fb
eurobio
antivir
assay
medium
use
contain
fb
human
coronaviru
hcov
propag
quantifi
cell
initi
viru
titer
calcul
cell
cultur
infecti
dose
accord
reed
muench
viru
stock
store
use
antivir
activ
pafb
paf
determin
evalu
reduct
virusinduc
cpe
character
round
vacuol
syncytia
format
cell
death
cell
monolay
one
day
infect
cellswel
seed
cultur
plate
next
day
medium
replac
fresh
medium
contain
dilut
viru
suspens
moi
ad
cell
cultur
follow
immedi
addit
cell
cultur
medium
supplement
fb
pafb
paf
plate
incub
hcov
strain
check
virusinduc
cpe
h
h
use
invert
light
microscop
motic
antivir
activ
protein
determin
crystal
violet
assay
adapt
feoktistova
et
antivir
activ
express
percentag
effect
cpeinhibitori
concentr
modif
cell
morpholog
reduct
virusinduc
cpe
also
microscop
determin
three
independ
experi
carri
triplic
immunofluoresc
stain
cell
fix
vv
formaldehyd
sigmaaldrich
subsequ
immers
pb
contain
vv
triton
cell
permeabil
sampl
block
bsa
wv
sigmaaldrich
hoechst
thermo
fischer
scientif
use
nuclear
counterstain
fix
cell
viral
capsid
detect
mous
monoclon
antihexon
antibodi
santa
cruz
biotechnolog
dilut
wv
bsa
primari
antibodi
incub
fix
cell
min
room
temperatur
wash
antigenantibodi
complex
detect
goat
antimous
fitclabel
secondari
antibodi
santa
cruz
biotechnolog
accord
grigorov
et
imag
acquir
use
invert
epifluoresc
microscop
axio
observ
carl
zeiss
gmbh
imag
imag
process
routin
perform
zen
softwar
carl
zeiss
gmbh
imagej
imagej
ecosystem
open
platform
biomed
imag
analysi
statist
analysi
perform
use
microsoft
excel
softwar
microsoft
corp
two
sampl
ttest
equal
varianc
onetail
distribut
use
data
gener
analys
studi
includ
publish
articl
supplementari
inform
file
